Skip to main content

#160879

anti-pan-MAGE A [M3H67]

Cat. #160879

anti-pan-MAGE A [M3H67]

Cat. #: 160879

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: pan-MAGE-A; including MAGE-A1, MAGE-A3, MAGE-A4, MAGE-A6 and MAGE-A10

Class: Monoclonal

Application: ELISA ; IHC ; WB

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Ludwig Institute for Cancer Research

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: anti-pan-MAGE A [M3H67]
  • Research fields: Cancer;Immunology
  • Clone: M3H67
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Host: Mouse
  • Application: ELISA ; IHC ; WB
  • Description: Cancer, Oncology, Tumor immunology, Cancer-Testis Antigen, Cancer Biomarker, Cancer Diagnostic

Target Details

  • Target: pan-MAGE-A; including MAGE-A1, MAGE-A3, MAGE-A4, MAGE-A6 and MAGE-A10

Applications

  • Application: ELISA ; IHC ; WB

Handling

  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Veit et al. 2016. Head Neck. 38(7):1008-16. PMID: 26874246.
  • Balafoutas et al. 2013. BMC Cancer. 13:271. PMID: 23731661.
  • Inaoka et al. 2011. BMC Cancer. 11(1):416. PMID: 21951388.
  • Figueiredo et al. 2011. Head Neck. 33(5):702-7. PMID: 20886663.
  • Perez et al. 2008. Int J Cancer. 123(7):1551-5. PMID: 18646188.
  • Oba-Shinjo et al. 2008. Cancer Immun. 8:7. PMID: 18426187.
  • Nelson et al. 2007. Cancer Immun. 7:1. PMID: 17217256.
  • Chitale et al. 2005. Mod Pathol. 18(1):119-26. PMID: 15272278.
  • L??ftl et al. 2004. Br J Dermatol. 151(6):1213-8. PMID: 15606517.
  • Lohmann et al. 2003. Melanoma Res. 13(6):595-601. PMID: 14646623.
  • Dhodapkar et al. 2003. Cancer Immun. 3:9. PMID: 12875607.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.